New York State Teamsters Council Health and Hospital Fund v. Pharmaceuticals
New York State Teamsters Council Health and Hospital Fund v. Jazz Pharmaceuticals, Inc.
- Richard Seeborg
- 3:20-cv-04056
- U.S. District Court · Northern District of California
- 3
Teamsters Council v. Jazz Pharmaceuticals: Judge Seeborg denied motions seeking transfer of cases from the multidistrict litigation court.
United HealthCare Services, Inc.; Blue Cross and Blue Shield of Florida, Inc.; Health Options, Inc.; Jazz Pharmaceuticals, Inc.; Hikma Pharmaceuticals USA Inc.; and their affiliates.
What happened
New York State Teamsters Council Health and Hospital Fund v. Jazz Pharmaceuticals, Inc. is part of multidistrict litigation concerning XYREM. United HealthCare Services and Florida Blue asked the court handling the coordinated cases to recommend sending their cases back to the courts where they began, arguing that pretrial work had ended after summary-judgment and expert-evidence motions were decided.
Jazz Pharmaceuticals, Hikma Pharmaceuticals, and their affiliates opposed the requests. They argued that pretrial work was still continuing, including expected motions about issues addressed in the earlier motions and other common issues affecting the coordinated cases.
Judge Richard Seeborg denied the motions for a suggestion of remand. He ruled that pretrial proceedings can include motions about what evidence may be used at trial and that continued coordination would benefit the cases.
The detailed version
- New York State Teamsters Council Health and Hospital Fund v. Pharmaceuticals · No. 3:20-cv-04056
- Richard Seeborg
- Feb. 28, 2025
Background
The case is part of the multidistrict litigation titled In re: XYREM (Sodium Oxybate) Antitrust Litigation. United HealthCare Services, Inc., and Blue Cross and Blue Shield of Florida, Inc., together with Health Options, Inc. (collectively, Florida Blue), moved under the rules governing multidistrict litigation for an order suggesting that the Judicial Panel on Multidistrict Litigation send their cases back to the courts where they were originally filed.
The plaintiffs argued that the coordinated pretrial proceedings had concluded because the transferee court had resolved all summary-judgment and expert-evidence challenges. The defendants—Jazz Pharmaceuticals, Inc., Hikma Pharmaceuticals USA Inc., and their affiliates—opposed remand. They pointed to anticipated substantive motions in limine, meaning motions addressing issues about evidence or other matters to be resolved before trial, and argued that pretrial proceedings remained ongoing.
Court’s Analysis
The court explained that the Judicial Panel on Multidistrict Litigation must return transferred cases to their original courts no later than the conclusion of pretrial proceedings. Courts have interpreted “pretrial proceedings” broadly to include motions in limine. The court rejected the plaintiffs’ reliance on an earlier antitrust multidistrict litigation decision because that court had ruled on motions in limine before granting remand.
The court also found that the coordinated proceeding continued to involve common questions affecting the individual cases. It cited ongoing docket activity, including a motion to prevent the defendants from introducing certain evidence. Coordinated proceedings allow one judge familiar with complex litigation to resolve common issues and reduce the risk of inconsistent results.
The plaintiffs also relied on a prior stipulated briefing schedule that they said placed their cases outside the schedule for motions in limine. The court held that the stipulation did not require remand. Because pretrial proceedings had not concluded, the court considered whether continued coordination would benefit the cases. It determined that continued consolidation would benefit them and stated that whether the defendants had preserved their right to oppose remand was irrelevant.
Disposition
Judge Richard Seeborg denied the plaintiffs’ motions for a suggestion of remand. The order did not send the cases back to their original courts.
Read the full 3-page opinion on CourtListener, the free public archive maintained by the Free Law Project.